Last reviewed · How we verify
Hydroxychloroquine and SoC
Hydroxychloroquine and SoC is a Small molecule drug developed by Christian Medical College, Vellore, India. It is currently FDA-approved. Also known as: Ipca HCQ® by IPCA Laboratories Ltd..
At a glance
| Generic name | Hydroxychloroquine and SoC |
|---|---|
| Also known as | Ipca HCQ® by IPCA Laboratories Ltd. |
| Sponsor | Christian Medical College, Vellore, India |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy? (PHASE4)
- The Potential Use of Inhaled Hydroxychloroquine for the Treatment of COVID-19 in Cancer Patients (PHASE1, PHASE2)
- Study of Efficacy and Safety of TL-FVP-t vs. SOC in Patients With Mild to Moderate COVID-19 (PHASE3)
- Evaluation of Safety and Efficacy of DCVAC/LuCa (Immunotherapy of Lung Cancer) in Patients With Metastatic Lung Cancer (PHASE1, PHASE2)
- COVID-19 Study at the Russian Clinical and Research Center of Gerontology of the Pirogov RNRMU
- The Potential Use of Nebulized Hydroxychloroquine for the Treatment of COVID-19 (PHASE2)
- A Study to Evaluate the Safety and Efficacy of Artemisinin- a Herbal Supplement on COVID-19 Subjects (PHASE4)
- Prevention and Treatment With Hydroxychloroquine + Azithromycin of Acute Respiratory Syndrome Induced by COVID-19 (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Hydroxychloroquine and SoC CI brief — competitive landscape report
- Hydroxychloroquine and SoC updates RSS · CI watch RSS
- Christian Medical College, Vellore, India portfolio CI
Frequently asked questions about Hydroxychloroquine and SoC
What is Hydroxychloroquine and SoC?
Hydroxychloroquine and SoC is a Small molecule drug developed by Christian Medical College, Vellore, India.
Who makes Hydroxychloroquine and SoC?
Hydroxychloroquine and SoC is developed and marketed by Christian Medical College, Vellore, India (see full Christian Medical College, Vellore, India pipeline at /company/christian-medical-college-vellore-india).
Is Hydroxychloroquine and SoC also known as anything else?
Hydroxychloroquine and SoC is also known as Ipca HCQ® by IPCA Laboratories Ltd..
What development phase is Hydroxychloroquine and SoC in?
Hydroxychloroquine and SoC is FDA-approved (marketed).
Related
- Manufacturer: Christian Medical College, Vellore, India — full pipeline
- Also known as: Ipca HCQ® by IPCA Laboratories Ltd.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing